Skip to content

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

PLOS BLOGS Speaking of Medicine and Health

This Week in PLOS Medicine: Screening for kidney disease; Xpert MTB/RIF; Ethics of cluster randomized trials

Image Credit: Dj jahir

Four new articles posted this week in PLOS Medicine, focusing on major health burdens and research design:

A systematic review of risk prediction models conducted by Justin Echouffo-Tcheugui and Andre Kengne examines the evidence base for prediction of chronic kidney disease risk and its progression, and the suitability of such models for clinical use.

Maarten Taal discusses the potential benefits, risks, and evidence base related to screening policies for chronic kidney disease, drawing on a new research article in PLOS Medicine.

Nicolas Menzies and colleagues investigate the potential impact and cost-effectiveness of implementing Xpert MTB/RIF for diagnosing tuberculosis in five southern African countries.

The Ottawa Ethics of Cluster Trials Consensus Group sets out 15 recommendations for the ethical design and conduct of cluster randomized trials.

Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Discussion
  1. […] Th&#1110&#1109 Week &#1110n PLOS Medicine: Screening f&#959r kidney disease; Xpert MTB/RIF … A systematic review &#959f risk prediction models conducted b&#1091 Justin Echouffo-Tcheugui &#1072nd Andre Kengne examines th&#1077 evidence base f&#959r prediction &#959f chronic kidney disease risk &#1072nd &#1110t&#1109 progression, &#1072nd th&#1077 suitability &#959f such models f&#959r clinical &#965&#1109&#1077. Read more &#959n PLoS Blogs (blog) […]

Leave a Reply

Your email address will not be published. Required fields are marked *


Add your ORCID here. (e.g. 0000-0002-7299-680X)

Back to top